Muscle ultrasonography: a potential new tool to diagnose and evaluate treatment in dermatomyositis and polymyositis
Recruiting
- Conditions
- Myositis10028302
- Registration Number
- NL-OMON34515
- Lead Sponsor
- niversitair Medisch Centrum Sint Radboud
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 154
Inclusion Criteria
1. Diagnostic value muscle ultrasound: patients suspected for the diagnosis inflammatory myopathies.
2. Monitoring disease activity: Patients diagnosed with dermatomyositis and polymyositis according to the Bohan & Peter criteria
3. Corticosteroïd myopathy: Patients suspected for the diagnose of a corticosteroïd myopathy
Exclusion Criteria
Patients suffering from other neuromuscular diseases.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>1. Diagnostic value muscle ultrasound: Sensitivity, specificity en predictive<br /><br>value<br /><br><br /><br>2. Monitoring disease activitiy muscle ultrasound: Correlation between muscle<br /><br>ultrasound and muscle strength/function (MRC and dynamometry), patient reported<br /><br>outcome (HAQ, SF-36, VAS patient and patient reported outcome questionnaire),<br /><br>Myositis Disease Activity Assessment Tool (MDAAT) and Myositis Damage index<br /><br>(MDI).<br /><br><br /><br>3. Corticosteroid myopathy: Structural muscle muscle changes defined by<br /><br>ultasound in patients with chronic corticosteroid use.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Not applicable</p><br>